IRIS
LANINI, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.414
NA - Nord America 1.658
EU - Europa 718
SA - Sud America 572
AF - Africa 35
OC - Oceania 4
Totale 5.401
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.568
SG - Singapore 1.088
BR - Brasile 471
CN - Cina 373
HK - Hong Kong 342
IT - Italia 244
VN - Vietnam 209
BD - Bangladesh 159
RU - Federazione Russa 111
FR - Francia 99
KR - Corea 80
GB - Regno Unito 46
CA - Canada 45
NL - Olanda 39
AR - Argentina 36
DE - Germania 36
IN - India 30
ID - Indonesia 28
MX - Messico 23
PL - Polonia 20
EC - Ecuador 18
SE - Svezia 18
IQ - Iraq 17
AT - Austria 16
ES - Italia 16
TR - Turchia 13
FI - Finlandia 12
CO - Colombia 11
IE - Irlanda 10
JP - Giappone 10
ZA - Sudafrica 10
UA - Ucraina 9
VE - Venezuela 9
PK - Pakistan 8
PY - Paraguay 8
CL - Cile 7
UY - Uruguay 7
KZ - Kazakistan 6
RO - Romania 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
MY - Malesia 5
BE - Belgio 4
CR - Costa Rica 4
EG - Egitto 4
GE - Georgia 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
PE - Perù 4
UZ - Uzbekistan 4
AU - Australia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
LT - Lituania 3
LV - Lettonia 3
NP - Nepal 3
TN - Tunisia 3
BY - Bielorussia 2
EE - Estonia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 5.397
Salva come PNG Salva come JPEG
Città #
Singapore 501
Hong Kong 339
Ashburn 237
Council Bluffs 153
Beijing 139
Boardman 124
San Jose 122
Lauterbourg 88
Dallas 87
Los Angeles 82
Hefei 79
Seoul 79
Ho Chi Minh City 69
Santa Clara 62
Hanoi 47
New York 39
Buffalo 38
Redondo Beach 38
The Dalles 34
São Paulo 32
Milan 22
Atlanta 21
Montreal 20
Warsaw 20
Amsterdam 18
Orem 18
Rome 17
Stockholm 16
Brooklyn 14
Chennai 13
Rio de Janeiro 13
Udine 12
Phoenix 11
Dublin 10
Frankfurt am Main 10
Guangzhou 10
Houston 10
Mexico City 10
San Francisco 10
Tokyo 10
Toronto 10
Chicago 9
Da Nang 9
Denver 9
Guayaquil 9
Haiphong 9
Vienna 9
Boston 8
Helsinki 8
Wuhan 8
Bologna 7
Campinas 7
Jakarta 7
Naples 7
Nuremberg 7
Pelotas 7
Porto Alegre 7
Quito 7
Tombolo 7
Baghdad 6
Bari 6
Brasília 6
Curitiba 6
Dhaka 6
Düsseldorf 6
Florence 6
Johannesburg 6
London 6
Manchester 6
Montevideo 6
Mumbai 6
Shenzhen 6
Asunción 5
Belford Roxo 5
Belo Horizonte 5
Biên Hòa 5
Cuiabá 5
Feira de Santana 5
Ha Long 5
Milwaukee 5
Ribeirão Preto 5
São José dos Campos 5
Thái Bình 5
Ankara 4
Belluno 4
Bogotá 4
Buenos Aires 4
Dong Ket 4
Figino 4
Goiânia 4
Itaquaquecetuba 4
Joinville 4
Kingston 4
Maceió 4
Madrid 4
Newark 4
Osasco 4
Phủ Lý 4
Pittsburgh 4
Quảng Ninh 4
Totale 3.026
Salva come PNG Salva come JPEG
Nome #
Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant 373
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 143
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study 130
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 110
Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: Outbreak investigation and infection outcome 104
Ebola virus disease complicated with viral interstitial pneumonia: A case report 93
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials 90
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia 89
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study) 89
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 88
Safety and Pharmacokinetic Profiles of Subcutaneous Administration of Beta-Lactams: A Systematic Review 87
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study 82
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 78
The middle east respiratory syndrome coronavirus – a continuing risk to global health security 76
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 75
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient 72
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 71
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 70
Escherichia coli producing AmpC DHA-1 bacteraemia in neutropenic leukemic patient: continuous infusion ceftazidime/avibactam as a carbapenem sparing regimen 69
Blood kinetics of Ebola virus in survivors and nonsurvivors 69
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital: USE OF ANTIVIRALS FOR MONKEYPOX IN AN ITALIAN HOSPITAL 68
Risk of infection in patients with lymphoma receiving rituximab: Systematic review and meta-analysis 67
COVID-19 disease - Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study 67
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study 66
Benefits of steroid therapy in COVID-19 patients with different PaO2/FiO2 ratio at admission 65
Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians 62
A large epidemic of hepatitis B in Serbia: An integrated model for outbreak investigations in healthcare settings 62
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH 61
Detection of recombinant breakpoint in the genome of human enterovirus E11 strain associated with a fatal nosocomial outbreak 60
Appropriateness of surgical antimicrobial prophylaxis in the Latium Region of Italy, 2008: A multicenter study 60
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017 60
Relationship between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study 59
Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects 59
Noninvasive positive-pressure ventilation 56
Ebola: Missed opportunities for Europe-Africa research 56
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 56
Temporal intra-host variability of mpox virus genomes in multiple body tissues 56
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis 55
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? 55
Patient to patient transmission of hepatitis B virus: A systematic review of reports on outbreaks between 1992 and 2007 55
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results 54
Author's reply: measles on a cruise ship--links with the outbreak in the Philippines 54
Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: A nationwide surveillance study 53
Liver transplant recipients and prioritization of anti-HCV therapy: An Italian cohort analysis 52
Epidemiology of HEV in the mediterranean basin: 10-year prevalence in Italy 52
Criteria for discharge of patients with Ebola virus diseases in high-income countries 51
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19 51
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study 51
Non-randomised Ebola trials-lessons for optimal outbreak research 51
Hospital cluster of HBV infection: Molecular evidence of patient-to-patient transmission through lancing device 50
Hepatitis C: global epidemiology and strategies for control 50
Viral hemorrhagic fevers: Advancing the level of treatment 50
Analysis of Diagnostic Findings from the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 49
High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: Evidence from outbreak investigation 49
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves 49
Local transmission of chikungunya in Rome and the lazio region, Italy 49
Incidence of SARS-CoV-2 Infection and Related Mortality by Education Level during Three Phases of the 2020 Pandemic: A Population-Based Cohort Study in Rome 49
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV 49
Cefepime-Taniborbactam in Complicated Urinary Tract Infection 49
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in PLWH 49
Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapy 48
Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years 48
Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries 47
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count 47
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study) 47
SELP Asp603Asn and severe thrombosis in COVID-19 males 47
Pulmonary involvement during the Ebola virus disease 47
Authors reply: measles on the cruise ship: links with virus spreading into an emergency department in Southern Italy 47
Epidemiology of viral hepatitis in men who have sex with men in Mediterranean Europe: a region-wide sero-surveillance in Rome (Italy) 46
The added value of long-lasting preparedness for the management of a patient with Ebola 46
Infections in patients taking Rituximab for hematologic malignancies: Two-year cohort study 46
Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser 44
Inflammatory and humoral immune response during ebola virus infection in survivor and fatal cases occurred in sierra leone during the 2014–2016 outbreak in west Africa 44
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV 44
Is hepatitis C virus eradication around the corner only 25 years after its discovery? 44
The surveillance of chikungunya virus in a temperate climate: Challenges and possible solutions from the experience of Lazio Region, Italy 43
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection 43
The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown 43
Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach 43
Influenza A (H1N1) in Rome, Italy in family: Three case reports 43
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox 42
Risk management of febrile respiratory illness in emergency departments 41
Short-term economic impact of the Zika virus outbreak 41
RE: Measles on the cruise ship: Links with virus spreading into an emergency department in southern Italy 41
Hepatitis C virus treatment revolution: Need for close monitoring 40
SARS-CoV-2 Early Screening at the Point of Entry: Travelers From Bangladesh to Italy–July 2020 40
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents 40
Measles cases during ebola outbreak, West Africa, 2013–2106 39
Reply to Reisler et al 39
Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection 37
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19 36
Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? 34
Hiv/hcv co-infection: Putting the pieces of the puzzle together 32
HIV Oral Pre-exposure Prophylaxis Effectiveness, Adherence, and Discontinuation in an Italian Multicentric Access Program: ItaPrEP Study 29
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease 26
Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmission 5
Totale 5.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 1 2 1
2022/20232 1 0 0 0 0 1 0 0 0 0 0 0
2023/20247 0 0 0 0 1 0 0 3 0 1 0 2
2024/20251.893 1 464 206 30 45 66 61 64 111 67 351 427
2025/20263.376 144 283 525 483 398 217 285 104 102 226 408 201
2026/2027451 451 0 0 0 0 0 0 0 0 0 0 0
Totale 5.743